05/13/2025
9:26 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
04/23/2025
7:14 PM | Arrowhead Pharmaceuticals (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/11/2025
5:20 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:35 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2025
3:44 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/17/2025
4:45 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:46 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2025
3:15 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B7 | |
03/05/2025
5:32 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:48 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
8:31 AM | Arrowhead Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for ARWR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/10/2025
5:23 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
4:57 PM | Arrowhead Pharmaceuticals (Issuer)
INGRAM DOUGLAS S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/07/2025
4:57 PM | Arrowhead Pharmaceuticals (Issuer)
INGRAM DOUGLAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
5:41 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SCHEDULE 13G | |
01/27/2025
6:22 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
3:43 PM | Arrowhead Pharmaceuticals (Subject)
OLUKOTUN ADEOYE Y (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
8:27 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
8:28 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
8:28 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:49 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
4:01 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
3:31 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
5:07 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:48 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:33 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:40 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:26 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:19 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
4:05 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
3:16 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024
4:12 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:23 PM | Arrowhead Pharmaceuticals (Subject)
OLUKOTUN ADEOYE Y (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:39 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:16 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
5:04 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
PERRY MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
OLUKOTUN ADEOYE Y (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad) So, unless you’ve been living under a rock, you probably saw the news…
Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯
We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer. 🎯 Click here to watch the video and get the free ticker XGPT just flagged. |
12/20/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:18 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:19 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:41 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
4:06 PM | Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
3:53 PM | Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:44 PM | Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:15 PM | Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
7:34 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
11/14/2024
8:38 AM | Arrowhead Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G | |
10/16/2024
8:15 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
Free ARWR Stock Alerts